Manulife Financial Corporation
$45.25+$0.49 (+1.09%)
Manulife Financial Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
NYSE · AFL · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Aflac Incorporated’s quoted price sits in the upper half of its reported 52-week range, 5.13% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Aflac Incorporated’s forward annual dividend is $2.44 per share, paid quarterly. The forward yield is 1.98% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Aflac Incorporated’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $1.80. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Aflac Incorporated’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Aflac Incorporated, operating through its various subsidiary companies, focuses on delivering supplementary health and life insurance policies. The firm's business activities are structured into two primary divisions: Aflac Japan and Aflac U.S. In Japan, the company offers a diverse range of insurance products, including coverage for cancer, medical expenses, income support for nursing care, and the distinct GIFT plan. This segment also provides traditional whole and term life insurance, along with savings-oriented plans like WAYS and child endowment products. Meanwhile, the Aflac U.S. division caters to the American market, furnishing policies that address cancer, accidents, short-term disability, critical illness, and hospital stays. Additionally, it provides dental, vision, long-term care, disability, and both term and whole life insurance options. Aflac distributes its comprehensive suite of products through multiple channels, which include dedicated sales associates, independent brokers, various corporate and individual agencies, and affiliated agencies. Established in 1955, the company maintains its corporate headquarters in Columbus, Georgia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 |
|---|
| Apr 30, 2025 |
| $1.66-0.6% vs estimate |
| $3.45B-19.28% vs estimate |
| Q4 2024 | Feb 5, 2025 | $1.56-3.7% vs estimate | $5.50B+26.98% vs estimate |
|---|
| Q3 2024 | Oct 30, 2024 | $2.16+27.81% vs estimate | $3.04B-29.41% vs estimate |
|---|
THE ANALYST VIEW
32 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 6 contributors · Median target $122.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$45.25+$0.49 (+1.09%)
Manulife Financial Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.94% below the high.
$100.83+$1.19 (+1.19%)
MetLife, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.72% below the high.
$116.87+$1.50 (+1.3%)
Prudential Financial, Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.5% below the high.
$132.06+$2.02 (+1.55%)
The Hartford Insurance Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 9.59% below the high.
$91.59+$1.34 (+1.48%)
Unum Group’s quoted price sits in the upper half of its reported 52-week range, 5.35% below the high.
$160.45+$2.08 (+1.31%)
Globe Life Inc.’s quoted price sits in the upper half of its reported 52-week range, 16.24% below the high.
$41.37+$0.71 (+1.75%)
Lincoln National Corporation’s quoted price sits in the upper half of its reported 52-week range, 13.22% below the high.
$55.17+$0.79 (+1.45%)
CNO Financial Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.2% below the high.